Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening

Columbia University · with Natera, Inc. · NCT07195071

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–55 · Women only
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
1000
US sites recruiting
1
Study start
February 12, 2026
Record last updated
October 21, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The investigators hypothesize that preconception and pregnancy may be a feasible and effective time to offer inherited cancer risk screening. This study will assess interest in cancer genetic testing among patients receiving routine prenatal care or preconception care. The goal is to evaluate the acceptability of hereditary cancer testing when offered alongside standard prenatal genetic screening. The study will also explore whether universal screening in this population could support early cancer prevention

Being studied: Natera empower comprehensive hereditary cancer panel; Obstetrical carrier screening

Conditions: Hereditary Cancer Syndrome

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion criteria

  • Age: 18 years - 55 years
  • Patients receiving obstetrical-related care at a CUMC-affiliated enrollment site
  • Patients who have elected to undergo OCS with the CUMC-affiliated obstetrics provider
  • Patients with prior OCS but planned to repeat OCS are eligible
  • Patients can speak and read in English or Spanish

Exclusion criteria

  • Patients who have previously completed a multigene hereditary cancer syndrome panel
  • Patients that have a hematologic cancer or hematologic pre-cancer
  • Patients who have a history of an autologous bone marrow transplant

Recruiting US locations

  • Columbia University Irving Medical Center

    New York, NY 10032

    Site contact: Jessica Giordano · 212-305-7250 · jlg2197@cumc.columbia.edu

Study contacts (from the official record)

  • Jessica Giordano · 212-305-7250 · jlg2197@cumc.columbia.edu
  • Reena Vattakalam · 212-342-6895 · rmv2110@cumc.columbia.edu
All pregnancy studies in New York →
Feasibility Trial of Combination of Obstetrical Carrier Screening… (NCT07195071) | Bored Studies